The filings point to a discounted equity raise ahead — dilution for existing holders. Next thing to watch: a 424B or offering 8-K. Support side: Insider buying cluster — insiders or holders bought while this setup is live; see the timeline.
Radar 88 (high attention) · dilution pressure high · listing risk low · governance risk low · runway 1.1 mo · strongest signal: Runway < 6 months (Jun 30, 2026)
What would confirm: 424B5/8-K announcing an offering, ATM sales disclosed in next 10-Q, or Form 4 sales by insiders ahead of it.
What would prove it wrong: Non-dilutive cash event (asset sale, grant, milestone payment), OCF turning positive, or shelf withdrawn (RW).
Direction is stated for existing shareholders (▼ more shares / survival or listing risk; ▲ insiders or holders buying). It is a characterization of the filings, not a forecast or a recommendation.
Independent filings stitched into a thesis, each with what would confirm and what would prove it wrong.
The filings point to a discounted equity raise ahead — dilution for existing holders. Next thing to watch: a 424B or offering 8-K. Cash need (runway < 6 months) coexists with live selling machinery (atm program, convertible note, equity line, pipe). Base case is a discounted raise; the question is when, not if.
Variable-priced paper is outstanding while the listing is under stress — the structure where dilution can accelerate. Watch the share count each quarter. Discount-priced or variable-priced securities are outstanding while the company is managing its listing with reverse splits/notices. Each conversion lowers the price, which lowers the next conversion price.
No note yet. Notes are written each morning for the top-ranked setups; Pro subscribers get them in full the same day.
Runway = liquidity ÷ monthly operating burn at the latest reported period · balance sheet 47 days old. A financing after the balance-sheet date is the main reason a figure can be stale — check the timeline below for offerings since then.
Last 30 days of filing signals plus current balance-sheet flags, newest first. ▼ pressure · ▲ support · hover a score for its components; every row links to the filing.
| Date | Signal | Evidence | Score |
|---|---|---|---|
| Aug 11, 2026 | ▼ Convertible note | “convertible note” language in 8-K (EX-10.1) filed 2026-08-11 filing | 45 |
| Aug 11, 2026 | ▼ Equity line | “equity line” language in 8-K (EX-4.2) filed 2026-08-11 filing | 45 |
| Aug 11, 2026 | ▼ ATM program | “atm” language in 8-K (EX-4.2) filed 2026-08-11 filing | 38 |
| Aug 11, 2026 | ▼ PIPE | “pipe” language in 8-K (8-K) filed 2026-08-11 filing | 33 |
| Aug 11, 2026 | ▼ Unregistered sale | 8-K Item 3.02 filed 2026-08-11 (accepted 16:40 ET) filing | 32 |
| Aug 11, 2026 | ▼ Reverse split | “reverse split” language in 8-K (EX-4.1) filed 2026-08-11 filing | 32 |
| Aug 11, 2026 | · Form 4 burst | 10 Form 4 filings in 30 days filing | 16 |
| Aug 7, 2026 | ▲ Insider buying cluster | 5 open-market buys by 5 insider(s) (~$134,000) in 30d: Mifek Jeffrey Gerald 3,[email protected] 2026-08-07; Sipos Jeremy Alexander 3,[email protected] 2026-08-07; Canning John Charles 4,[email protected] 2026-08-07; Elefant Dov 15,[email protected] 2026-08-07 filing | 46 |
| Jun 30, 2026 | ▼ Runway < 6 months | ~1.1 months runway: liquidity $1,443,502 as of 2026-06-30, burn $16,382,816/yr (annualized 180-day YTD operating cash flow [companyfacts]) filing | 48 |
| Jun 30, 2026 | ▼ Cash < current liabilities | Liquidity $1,443,502 vs current liabilities $3,886,826 filing | 21 |
VIVS VivoSim Labs, INC. · HCWB HCW Biologics Inc. · CYCU Cycurion, Inc. · BIAF bioAffinity Technologies, In · XHLD TEN Holdings, Inc. · VSEE VSEE HEALTH, INC. · screener →